Description

(6-Bromoimidazo[1,2-A]Pyridin-3-Yl)-N,n-Dimethylmethanamine Hydrochloride is a high-purity, advanced pharmaceutical intermediate with a distinct brominated imidazopyridine core structure. This compound is critical for medicinal chemistry research and development, serving as a versatile building block for the synthesis of novel bioactive molecules. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing new therapeutic agents, particularly in oncology and CNS drug discovery.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of potential drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used as a scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Kinase Inhibitor Development: The imidazopyridine moiety is valuable for creating compounds that modulate kinase activity, relevant in cancer research.
• Chemical Biology Probes: Employed in the design and synthesis of molecular probes for studying biological processes and target validation.
• Custom Synthesis: Serves as a starting material for contract research organizations (CROs) and CDMOs performing bespoke synthetic routes for clients.
• Academic Research: Used in university and institutional labs for fundamental research in heterocyclic chemistry and bioorganic chemistry.

Basic Information

Product Name	(6-Bromoimidazo[1,2-A]Pyridin-3-Yl)-N,n-Dimethylmethanamine Hydrochloride
CAS No.	1134570-17-4
Molecular Formula	C₁₀H₁₁BrClN₃
Molecular Weight	288.57 g/mol
Synonyms	6-Bromo-3-[(dimethylamino)methyl]imidazo[1,2-a]pyridine hydrochloride; N,N-Dimethyl-1-(6-bromoimidazo[1,2-a]pyridin-3-yl)methanamine hydrochloride; 6-Bromo-3-(dimethylaminomethyl)imidazo[1,2-a]pyridine HCl; 1134570-17-4; (6-Bromoimidazo[1,2-a]pyridin-3-yl)-N,N-dimethylmethanamine hydrochloride; 6-Bromoimidazo[1,2-a]pyridine-3-methanamine, N,N-dimethyl-, hydrochloride
EINECS	Contact for details

Quality Control

Our (6-Bromoimidazo[1,2-A]Pyridin-3-Yl)-N,n-Dimethylmethanamine Hydrochloride is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and tests for residual solvents and heavy metals to ensure it meets the stringent requirements for pharmaceutical R&D. Certificates of Analysis (COA) with full traceability are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Heavy Metals	< 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.